Anti-inflammatory effects of Cu,Zn-Superoxide dismutase in Transfersomes,
micelles or liposomes, in the acute murine ear oedema model.
S.I. Simões*, M. B. F. Martins*, M. E. M. Cruz*, G. Cevc+
*UNFAB, Department of Biotechnology, IBQTA, Instituto Nacional
de Engenharia e Tecnologia Industrial, Estrada do Paço do Lumiar, 1699
Lisboa Codex, Portugal;
+Medical Biophysics, Klinikum r.d.I., The Technical University of Munich,
Ismaningerstr. 22, D-81675 München, Germany
In: Proceedings of Control Release Society Satellite
Meeting in Lisbon, 1998.
Superoxide radicals are involved in a variety of pathologic
situations, such as ischemia-reperfusion injury, inflammation and radiation
damage. Cu,Zn-Superoxide-dismutase (Cu,ZnSOD), with known antioxidant
and anti-inflammatory properties, has been suggested as therapeutic agent
for treating such conditions. However, this enzyme has a very short half-live
in the bloodstream. Frequent injections are therefore required to maintain
therapeutic drug concentration in the blood, which results in poor patient
compliance and in oscillating systemic concentration levels. Recently,
there has been increased interest in drug administration via the skin,
both for the local treatment of the diseased skin (topical delivery) and
for systemic therapy (transdermal delivery). However, to reach these goals
one must achieve good efficiency of protein transport across the skin.
Composite, ultradeformable drug carriers, Transfersomes, were argued to
deliver small as well as large molecules through the skin. Via the lymph,
the epicutaneously delivered material can also reach the blood circulation.
This was observed with the specially optimised lipid mixtures in the form
of vesicles (often comprising phospholipids and detergents) after non-occlusive
percutaneous administration. The process is believed to be driven by the
transepidermal water activity gradient. This can push sufficiently hydrophilic
entities through the skin barrier, if the penetration resistance is small
enough due to the high flexibility of the complex vesicles membranes.
Properly designed Transfersomes used as carriers can ensure the efficiency
of drug transfer across the skin, and the resulting biodistribution, to
resemble that achieved by subcutaneous injections. The effects of topically
applied Cu,Zn-SOD on local inflammation were investigated in the acute
murine ear oedema model. Ear swelling was induced by topical application
of arachidonic acid (=AA, 2 mg in EtOH/ear). Edema-suppression by the
epicutaneously applied Cu,Zn-SOD associated with Transfersomes, corresponding
mixed micelles, or liposomes was measured, using empty vehicles as negative
controls for each group. Positive reference groups were treated epicutaneously
with several low molecular weight nonsteroidal anti-inflammatory agents.
Of all carriers tested, only the enzyme-loaded Transfersomes (60 µg SOD/kg)
reduced the swelling of ears significantly, by (73±10) %. Aqueous enzyme
solution had no such effect. Indomethacin (3 mg/kg), etofenamate (30 mg/kg)
and piroxicam (3 mg/kg) reduced the oedema by (83±7) %, (64±3) % and (40±10)
%, respectively. Microscopic evaluation of haematoxylin and eosin-stained
histological sections, prepared from the formalin-fixed ears, confirmed
that Cu,Zn-SOD-loaded Transfersomes reduce the local tissue inflammation.
The fact that untreated ears or the tissues treated with the empty carriers
revealed much stronger epidermal hyperplasia and infiltration of inflammatory
cells corroborates such conclusion. The acute model of inflammation based
on AA has a limited value for determining the mechanism of drug action.
This test is generally accepted, however, for studying the anti-inflammatory
action of drugs in the first stage trials. Our results are therefore encouraging
but further investigations with chronic models should establish the potential
usefulness of Cu,Zn-SOD in Transfersomes for proper inflammation therapy.
<---- |
Startseite |
Über uns |
Corporate Factsheet |
Wissenschaft |
Publikationen |
Einsatzmöglichkeiten |
Finanzierung |
Pressemitteilungen |
Letzter Newsletter |
Pressespiegel |
Konferenzen |
Karriere |
Kontakt |
Wissenschaftliche FAQ |
Glossar |
Seitenübersicht |
Suchen |